Vercise DBS
Total Payments
$43,160
Transactions
2
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $43,160 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $43,160 | 2 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Pilot study to evaluate DBS on the LHA on metabolism weight loss and feeding behavior in patients with chronic refractory obesity | Boston Scientific Corporation | $22,000 | 0 |
| Effects of Deep Brain Stimulation DBS of the Pedunculopontine Nucleus PPN on Gait Postural Stability Freezing of Gait FOG and Falls | Boston Scientific Corporation | $21,160 | 0 |
Top Doctors Receiving Payments for Vercise DBS
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Litchfield Park, AZ | $43,160 | 2 |
Ad
Manufacturing Companies
- Boston Scientific Corporation $43,160
Product Information
- Type Device
- Total Payments $43,160
- Total Doctors 0
- Transactions 2
About Vercise DBS
Vercise DBS is a device associated with $43,160 in payments to 0 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is Boston Scientific Corporation.
Payment data is available from 2023 to 2023. In 2023, $43,160 was paid across 2 transactions to 0 doctors.
The most common payment nature for Vercise DBS is "Unspecified" ($43,160, 100.0% of total).
Vercise DBS is associated with 2 research studies, including "Pilot study to evaluate DBS on the LHA on metabolism weight loss and feeding behavior in patients with chronic refractory obesity" ($22,000).